← All research updates

Testing Cesium-131 GammaTiler for Older or Frail Adults With Glioma

Original title: Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Tx Treated With Cesium-131 GammaTile®

How far along is this research?

This is a trial that is enrolling or has been updated. It is not a finding yet.

This is a mid-stage test to learn if the treatment is safe and workable.

Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.

The trial team last updated this record on . Always check the trial page for the latest.

The short version

This study looks at whether a treatment called GammaTiler is safe for older or frail people with a glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary brain tumor.

Who this trial is for. This trial is for older or frail people with a malignant glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary. It includes people who were just diagnosed and people whose tumor came back. It is testing a treatment called Cesium-131 GammaTiler.

Where it stands. The trial will look at whether this treatment can be given, whether it is safe, and how well people handle it. It has not reported any results yet.

What this means, and what it doesn't

What it could mean: Researchers want to learn if this treatment is a safe choice for older or frail people. If you think you might fit, you could ask your care team about it. The trial team decides who can join.

What it doesn't mean: A trial is a test, not a proven treatment. Being in a trial does not promise that it will help you. This is not a cure.

Source: ClinicalTrials.gov, September 15, 2026 · Read the original

This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.

Report a problem with this summary